Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid

Area of Science:

• Microbiology
• Bacterial Pathogenesis
• Antibiotic Susceptibility

Background:

• Chlamydia trachomatis is an obligate intracellular bacterium responsible for various human infections.
• Understanding the mechanisms of antibiotic action against Chlamydia is crucial for developing effective treatments.
• The cell wall composition and penicillin-binding proteins (PBPs) of Chlamydia are not fully elucidated.

Purpose of the Study:

• To investigate the effects of benzylpenicillin on Chlamydia trachomatis LGV-434.
• To identify potential penicillin targets within Chlamydia trachomatis.
• To determine the susceptibility of Chlamydia trachomatis to penicillin.

Main Methods:

• Cultivation of Chlamydia trachomatis LGV-434 in HeLa 229 cells.
• Treatment with varying concentrations of benzylpenicillin.
• Identification and molecular weight determination of penicillin-binding proteins (PBPs) using Sarkosyl-soluble fractions.
• Quantification of penicillin binding to PBPs in both elementary bodies (EBs) and reticulate bodies (RBs).
• Analysis of muramic acid content in Chlamydia trachomatis.

Main Results:

• Benzylpenicillin completely inhibited infectious elementary body (EB) formation at concentrations of 19 pmol/ml and higher.
• Abnormally large reticulate bodies (RBs) were observed at benzylpenicillin concentrations of 30 pmol/ml and higher.
• Three PBPs with apparent molecular weights of 88,000 (PBP 1), 61,000 (PBP 2), and 36,000 (PBP 3) were identified in both RBs and EBs.
• The 50% penicillin binding concentrations for these PBPs ranged from 7 to 70 pmol/ml.
• Chlamydia trachomatis showed high susceptibility to penicillin despite lacking detectable muramic acid.

Conclusions:

• Benzylpenicillin effectively inhibits Chlamydia trachomatis replication and affects its developmental cycle.
• Penicillin-binding proteins (PBPs) are likely targets for penicillin's action in Chlamydia trachomatis.
• The susceptibility of Chlamydia trachomatis to penicillin, even without significant muramic acid, warrants further investigation into its cell wall synthesis and PBP function.